Arnold Stronkhorst

947 total citations
22 papers, 310 citations indexed

About

Arnold Stronkhorst is a scholar working on Surgery, Genetics and Immunology. According to data from OpenAlex, Arnold Stronkhorst has authored 22 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 7 papers in Genetics and 7 papers in Immunology. Recurrent topics in Arnold Stronkhorst's work include Inflammatory Bowel Disease (7 papers), Bariatric Surgery and Outcomes (3 papers) and Diet and metabolism studies (3 papers). Arnold Stronkhorst is often cited by papers focused on Inflammatory Bowel Disease (7 papers), Bariatric Surgery and Outcomes (3 papers) and Diet and metabolism studies (3 papers). Arnold Stronkhorst collaborates with scholars based in Netherlands, Germany and Ireland. Arnold Stronkhorst's co-authors include Lennard P. L. Gilissen, Sandra A. Radema, S J van Deventer, Sandro L. Yong, I J ten Berge, G. N. J. Tytgat, Grard A. P. Nieuwenhuijzen, Ad Masclee, S. J. H. Van Deventer and L.G.J.B. Engels and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Gut.

In The Last Decade

Arnold Stronkhorst

19 papers receiving 305 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arnold Stronkhorst Netherlands 9 157 100 91 77 50 22 310
Justin Côté-Daigneault Canada 9 132 0.8× 96 1.0× 141 1.5× 75 1.0× 23 0.5× 17 311
Takahiko Toyonaga Japan 13 253 1.6× 104 1.0× 230 2.5× 70 0.9× 31 0.6× 30 438
Ivan Ferkolj Slovenia 11 276 1.8× 120 1.2× 193 2.1× 111 1.4× 48 1.0× 23 416
C. Bascietto Italy 7 283 1.8× 98 1.0× 201 2.2× 96 1.2× 39 0.8× 11 359
Makoto Yamamura Japan 8 195 1.2× 41 0.4× 138 1.5× 107 1.4× 17 0.3× 12 342
Ignace Dalle Belgium 7 178 1.1× 132 1.3× 193 2.1× 60 0.8× 23 0.5× 14 410
Marie Carlson Sweden 9 169 1.1× 94 0.9× 169 1.9× 95 1.2× 12 0.2× 15 393
Sean Fine United States 8 157 1.0× 81 0.8× 93 1.0× 204 2.6× 19 0.4× 28 428
Bunei Iizuka Japan 8 132 0.8× 61 0.6× 84 0.9× 54 0.7× 18 0.4× 26 285
WJ Sandborn United States 10 234 1.5× 107 1.1× 212 2.3× 37 0.5× 22 0.4× 21 360

Countries citing papers authored by Arnold Stronkhorst

Since Specialization
Citations

This map shows the geographic impact of Arnold Stronkhorst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnold Stronkhorst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnold Stronkhorst more than expected).

Fields of papers citing papers by Arnold Stronkhorst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnold Stronkhorst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnold Stronkhorst. The network helps show where Arnold Stronkhorst may publish in the future.

Co-authorship network of co-authors of Arnold Stronkhorst

This figure shows the co-authorship network connecting the top 25 collaborators of Arnold Stronkhorst. A scholar is included among the top collaborators of Arnold Stronkhorst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnold Stronkhorst. Arnold Stronkhorst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Avesaat, Mark van, et al.. (2024). Peptide YY and Glucagon-like Peptide-1 Secretion in Obesity. SHILAP Revista de lepidopterología. 7(1). 3–3. 2 indexed citations
3.
Tedjo, Danyta I., Jos Boekhorst, Harro M. Timmerman, et al.. (2023). Impact of Sleeve Gastrectomy on Fecal Microbiota in Individuals with Morbid Obesity. Microorganisms. 11(9). 2353–2353. 3 indexed citations
4.
Schoon, Erik J., et al.. (2023). Relapse rates after withdrawal versus maintaining biologic therapy in IBD patients with prolonged remission. Clinical and Experimental Medicine. 23(6). 2789–2797. 6 indexed citations
5.
Gilissen, Lennard P. L., Erik J. Schoon, Annemarie M. J. Wensing, et al.. (2021). Neither inflammatory bowel disease nor immunosuppressants are associated with an increased risk of severe COVID-19: an observational Dutch cohort study. Clinical and Experimental Medicine. 22(3). 465–476. 7 indexed citations
6.
Gilissen, Lennard P. L., Arnold Stronkhorst, Peter H. N. de With, et al.. (2021). Algorithm combining virtual chromoendoscopy features for colorectal polyp classification. SHILAP Revista de lepidopterología. 9(10). E1497–E1503.
7.
Bernards, Nienke, Zlatan Mujagic, Mark van Avesaat, et al.. (2019). Intestinal barrier function in morbid obesity: results of a prospective study on the effect of sleeve gastrectomy. International Journal of Obesity. 44(2). 368–376. 27 indexed citations
9.
Schoon, Erik J., et al.. (2016). Antibacterial gauzes are effective in preventing infections after percutaneous endoscopic gastrostomy placement. European Journal of Gastroenterology & Hepatology. 28(3). 297–304. 5 indexed citations
11.
Gilissen, Lennard P. L., Dennis R. Wong, L.G.J.B. Engels, et al.. (2012). Therapeutic drug monitoring of thiopurine metabolites in adult thiopurine tolerant IBD patients on maintenance therapy. Journal of Crohn s and Colitis. 6(6). 698–707. 56 indexed citations
12.
Deventer, Sander J. H. van, Daniël W. Hommes, Willem Dekker, et al.. (2001). Prospective randomized open label blinded endpoint (PROBE) trial of high versus low dose mesalazine for prevention of relapse in patients with UC in remission. Gastroenterology. 120(5). A454–A454. 7 indexed citations
13.
Meulen, Cornelis G. ter, et al.. (1997). Cytomegalovirus-associated gastric ulcers in a patient with celiac disease: coincidence or association?. PubMed. 92(10). 1933–4.
14.
Stronkhorst, Arnold, Sandra A. Radema, Sandro L. Yong, et al.. (1997). CD4 antibody treatment in patients with active Crohn's disease: a phase 1 dose finding study.. Gut. 40(3). 320–327. 87 indexed citations
15.
16.
Radema, Sandra A., et al.. (1995). Anti-CD4 therapy decreases epithelial expression of HLA-DR molecules in patients with Crohn's disease. Inflammatory Bowel Diseases. 1(3). 193–197. 9 indexed citations
17.
Radema, Sandra A., et al.. (1995). Anti-CD4 Therapy Decreases Epithelial Expression of HLA-DR Molecules in Patients with Crohn’s Disease. Inflammatory Bowel Diseases. 1(3). 193–197. 4 indexed citations
18.
Stronkhorst, Arnold, G. N. J. Tytgat, & S. J. H. Van Deventer. (1992). CD4 Antibody Treatment in Crohn's Disease. Scandinavian Journal of Gastroenterology. 27(sup194). 61–65. 16 indexed citations
19.
Stronkhorst, Arnold, A. Bosma, & Dirk J. van Leeuwen. (1992). A case of labetalol-induced hepatitis.. PubMed. 40(3-4). 200–2. 5 indexed citations
20.
Radema, Sandra A., Daan W. Hommes, Paul Fockens, et al.. (1992). Cytokine Induction in Experimental and Ulcerative Colitis. Digestive Surgery. 9(4). 177–182. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026